Cumulus Oncology
4 known investors
Cumulus Oncology builds a risk-adjusted portfolio of preclinical-stage oncology drug assets, using a platform-agnostic, data- and milestone-driven curation process to advance cancer therapeutics for defined patient populations with high unmet medical need. The company aims to improve drug development success rates and create value through partnering, licensing, and exit opportunities for investors.
Founders & leadership
CW
Clare WareinginCEO
Investors · 4
Frequently asked questions
- What does Cumulus Oncology do?
- Cumulus Oncology builds a risk-adjusted portfolio of preclinical-stage oncology drug assets, using a platform-agnostic, data- and milestone-driven curation process to advance cancer therapeutics for defined patient populations with high unmet medical need. The company aims to improve drug development success rates and create value through partnering, licensing, and exit opportunities for investors.
- Who are Cumulus Oncology's investors?
- Cumulus Oncology's investors include Alba Equity, Apollo Informal Investment, Eos Advisory, Scottish National Investment Bank.